Exact Therapeutics Financials
| EXTX Stock | NOK 3.78 0.06 1.56% |
Exact |
Understanding current and past Exact Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Exact Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Exact Therapeutics' assets may result in an increase in income on the income statement.
Exact Therapeutics Stock Summary
Exact Therapeutics competes with Nidaros Sparebank, Kraft Bank, Clean Seas, Awilco Drilling, and NorAm Drilling. EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010852213 |
| Business Address | stre Aker vei |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.exact-tx.com |
| Currency | NOK - Kroner |
You should never invest in Exact Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Exact Stock, because this is throwing your money away. Analyzing the key information contained in Exact Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Exact Therapeutics Key Financial Ratios
There are many critical financial ratios that Exact Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Exact Therapeutics reports annually and quarterly.| Return On Equity | -0.46 | |||
| Return On Asset | -0.26 | |||
| Beta | 0.21 |
Exact Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Exact Therapeutics's current stock value. Our valuation model uses many indicators to compare Exact Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exact Therapeutics competition to find correlations between indicators driving Exact Therapeutics's intrinsic value. More Info.Exact Therapeutics AS is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exact Therapeutics' earnings, one of the primary drivers of an investment's value.Exact Therapeutics Systematic Risk
Exact Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Exact Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Exact Therapeutics correlated with the market. If Beta is less than 0 Exact Therapeutics generally moves in the opposite direction as compared to the market. If Exact Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Exact Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Exact Therapeutics is generally in the same direction as the market. If Beta > 1 Exact Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Exact Therapeutics December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Exact Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Exact Therapeutics AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Exact Therapeutics AS based on widely used predictive technical indicators. In general, we focus on analyzing Exact Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Exact Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 43.91 | |||
| Value At Risk | (5.45) | |||
| Potential Upside | 5.45 |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.